A Truly Injectable Neural Stimulation Electrode Made from an In-Body Curing Polymer/Metal Composite

James K. Trevathan,Ian W. Baumgart,Evan N. Nicolai,Brian A. Gosink,Anders J. Asp,Megan L. Settell,Shyam R. Polaconda,Kevin D. Malerick,Sarah K. Brodnick,Weifeng Zeng,Bruce E. Knudsen,Andrea L. McConico,Zachary Sanger,Jannifer H. Lee,Johnathon M. Aho,Aaron J. Suminski,Erika K. Ross,J. Luis Lujan,Douglas J. Weber,Justin C. Williams,Manfred Franke,Kip A. Ludwig,Andrew J. Shoffstall
DOI: https://doi.org/10.1101/584995
2019-03-21
Abstract:Abstract Implanted neural stimulation and recording devices hold vast potential to treat a variety of neurological conditions, but the invasiveness, complexity, and cost of the implantation procedure greatly reduce access to an otherwise promising therapeutic approach. To address this need, we have developed a novel electrode that begins as an uncured, flowable pre-polymer that can be injected around a neuroanatomical target to minimize surgical manipulation. Referred to as the Injectrode, the electrode conforms to target structures forming an electrically conductive interface which is orders of magnitude less stiff than conventional neuromodulation electrodes. To validate the Injectrode, we performed detailed electrochemical and microscopy characterization of its material properties and validated the feasibility of using it to electrically stimulate the nervous system in rats and swine. The silicone-metal-particle composite performed very similarly to pure wire of the same metal (silver) in all measures, including exhibiting a favorable cathodic charge storage capacity (CSC C ) and charge injection limits compared to the clinical LivaNova stimulation electrode and silver wire electrodes. By virtue of being simpler than traditional electrode designs, less invasive, and more cost-effective, the Injectrode has the potential to increase the adoption of neuromodulation therapies for existing and new indications.
What problem does this paper attempt to address?